Abstract
Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare. Approximately 85% of GISTs are driven by oncogenic mutations in either of two receptor tyrosine kinases: KIT or platelet-derived growth factor receptor α. We review the pivotal relationship between specific mutations in these kinase genes, the origin and pathologic spectrum of GISTs, and the response of these tumors to treatment with kinase inhibitors such as imatinib and sunitinib. Mechanisms of resistance to kinase inhibitor therapy are discussed, and targets for the next generation of therapeutics are considered. The rapid evolution in our understanding of GISTs, which stems directly from the close alliance of basic and clinical researchers in the field, illustrates the growing role of the molecular classification of solid tumors in the development of modern oncological treatments.
Keywords
SunitinibImatinibGiSTPDGFRACancer researchTyrosine kinaseStromal cellTyrosine-kinase inhibitorReceptor tyrosine kinaseTargeted therapyBiologyMedicineKinaseBioinformaticsCancerReceptorInternal medicineGenetics
Affiliated Institutions
Related Publications
Diagnosing and Managing Advanced Chronic Myeloid Leukemia
Clinical staging of chronic myeloid leukemia (CML) distinguishes between chronic phase (CP-CML), accelerated phase (AP-CML), and blastic phase (BP-CML), reflecting its natural h...
Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats.
A growing body of evidence has suggested that oxidative stress causes cardiac injuries during ischemia/reperfusion. Extracellular signal-regulated kinases (ERKs) have been repor...
Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions
Over 90% of all cancers are carcinomas, malignancies derived from cells of epithelial origin. As carcinomas progress, these tumors may lose epithelial morphology and acquire mes...
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of <i>EGFR</i>
Abstract Background Malignant astrocytic gliomas in children show a remarkable biological and clinical diversity. Small in-frame insertions or missense mutations in the epiderma...
Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management
Disease overview : Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1–2 cases per 100,000 adults, and accounts for ∼15% of newly diagnosed ca...
Publication Info
- Year
- 2008
- Type
- review
- Volume
- 3
- Issue
- 1
- Pages
- 557-586
- Citations
- 310
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
310
OpenAlex
Cite This
Christopher L. Corless,
Michael C. Heinrich
(2008).
Molecular Pathobiology of Gastrointestinal Stromal Sarcomas.
Annual Review of Pathology Mechanisms of Disease
, 3
(1)
, 557-586.
https://doi.org/10.1146/annurev.pathmechdis.3.121806.151538
Identifiers
- DOI
- 10.1146/annurev.pathmechdis.3.121806.151538